Press release from Business Wire
ARIAD to Present at the Jefferies 2011 Global Healthcare Conference in London
Thursday, September 22, 2011
CAMBRIDGE, Mass. (Business Wire) -- ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced that it will present at the Jefferies 2011 Global Healthcare Conference in London. Harvey J. Berger, M.D., chairman and chief executive officer, will provide an overview of the Company's robust oncology pipeline and progress on its three lead compounds on Wednesday, September 28 at 8:40 a.m. local time.
The ARIAD presentation will be webcast live and can be accessed by visiting the investor relations section of the Company's website at http://www.ariad.com/investor. A replay of the presentation will also be available and archived on the site for three weeks.
ARIAD Pharmaceuticals, Inc. is an emerging global oncology company focused on the discovery, development and commercialization of medicines to transform the lives of cancer patients. ARIAD's approach to structure-based drug design has led to three internally discovered, molecularly targeted product candidates for drug-resistant and difficult-to-treat cancers, including certain forms of chronic myeloid leukemia, soft tissue and bone sarcomas and non-small cell lung cancer. For additional information, visit http://www.ariad.com.
ARIAD Pharmaceuticals, Inc.
Maria E. Cantor, 617-621-2208
Liza Heapes, 617-621-2315